Evotec SE (EVOTF) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ... [Yahoo! Finance]
Evotec SE (EVO)
NASDAQ:AMEX Investor Relations:
eatonvance.com
Company Research
Source: Yahoo! Finance
Just Evotec Biologics Revenue: Increased by 74% to EUR128.7 million from EUR74.1 million. Adjusted Group EBITDA: Minus EUR6 million for the nine months. R&D Spending: Reduced by 15% to EUR41.1 million from EUR48.4 million. Gross Margin: Improved from 8.6% in Q2 to 9.8% in Q3. Free Cash Flow: Positive EUR16.7 million in Q3, compared to negative EUR80 million in Q1 and Q2. Liquidity: Increased to EUR303 million in Q3 from EUR299 million in Q2. Financial Liabilities: Totaling EUR467 million, with 95% carrying fixed interest rates. Guidance for 2024: Group revenues expected between EUR790 million and EUR820 million; adjusted EBITDA expected to reach EUR15 million to EUR35 million. Priority Reset Savings Target: EUR40 million annual savings by end of 2025, with 60% of the run rate savings already implemented. Warning! GuruFocus has detected 5 Warning Signs with EVOTF. Release Date: November 06, 2024 For the complete transcript of the earnings call, please refer to th
Show less
Read more
Impact Snapshot
Event Time:
EVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVO alerts
High impacting Evotec SE news events
Weekly update
A roundup of the hottest topics
EVO
News
- Comment on Media Report [Yahoo! Finance]Yahoo! Finance
- Comment on Media ReportAccesswire
- Evotec SE (NASDAQ: EVO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.MarketBeat
- Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions [Yahoo! Finance]Yahoo! Finance
- Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market ConditionsAccesswire